Iht Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Iht Wealth Management, LLC

$3.44 Billion
Q3 2024

A detailed history of Iht Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Iht Wealth Management, LLC holds 701 shares of REGN stock, worth $530,523. This represents 0.02% of its overall portfolio holdings.

Number of Shares

701

Previous 598 17.22%

Holding current value

$530,523

Previous $628,000 17.2%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $105,481 - $123,781	103 Added 17.22%	701 $736,000
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $883 - $1,071	-1 Reduced 0.17%	598 $628,000
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $14,443 - $15,893	-16 Reduced 2.6%	599 $576,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $31,007 - $35,268	40 Added 6.96%	615 $540,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $9,694 - $11,821	14 Added 2.5%	575 $473,000
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $11,900 - $14,115	17 Added 3.13%	561 $403,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $11,568 - $14,058	17 Added 3.23%	544 $446,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $86,824 - $94,265	-123 Reduced 18.92%	527 $380,000
Q3 2022 Nov 22, 2022	BUY	$573.97 - $724.32 $153,249 - $193,393	267 Added 69.71%	650 $448,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $16,450 - $22,165	-30 Reduced 7.26%	383 $226,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $12,497 - $14,667	21 Added 5.36%	413 $288,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $10,326 - $12,748	19 Added 5.09%	392 $248,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $138,915 - $164,792	-242 Reduced 39.35%	373 $226,000
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $2,364 - $2,792	5 Added 0.82%	615 $344,000
Q1 2021 May 18, 2021	SELL	$446.73 - $548.2 $10,274 - $12,608	-23 Reduced 3.63%	610 $289,000
Q4 2020 Feb 17, 2021	BUY	$478.3 - $607.98 $18,175 - $23,103	38 Added 6.39%	633 $306,000
Q3 2020 Nov 19, 2020	SELL	$544.75 - $658.21 $561,092 - $677,956	-1,030 Reduced 63.38%	595 $333,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $552,025 - $720,546	1,119 Added 221.15%	1,625 $1.01 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $170,107 - $250,181	506 New	506 $247,000
Q1 2019 May 16, 2019	SELL	$372.08 - $439.57 $483,704 - $571,441	-1,300 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$335.82 - $403.04 $42,649 - $51,186	-127 Reduced 8.9%	1,300 $486,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $98,319 - $114,382	-280 Reduced 16.4%	1,427 $577,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $49,235 - $59,683	173 Added 11.28%	1,707 $589,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $23,054 - $28,745	73 Added 5.0%	1,534 $507,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $508,537 - $666,389	1,418 Added 3297.67%	1,461 $544,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $18,549 - $21,672	43	43 $20,000

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.

Account

Iht Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History